Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Receivables - Other (2011 - 2026)

Analysis

Cerenome (CNSY) Receivables - Other (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Cerenome 20.42 Mn 11.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.76 Mn
Mar 31, 2026 1.35 Mn
Dec 31, 2025 322,000.00
Jun 30, 2025 1.02 Mn
Dec 31, 2024 571,000.00
Sep 30, 2023 91,000.00
Jun 30, 2023 718,000.00
Sep 30, 2022 73,000.00
Dec 31, 2019 144,000.00
Dec 31, 2018 55,000.00
Dec 31, 2017 112,000.00
Dec 31, 2016 51,000.00
Dec 31, 2015 260,000.00
Dec 31, 2014 117,000.00
Dec 31, 2013 111,000.00
Dec 31, 2012 111,000.00
Dec 31, 2011 231,000.00